Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population

被引:0
|
作者
Decarreaux, Dorine [1 ,2 ,3 ]
Sevila, Julie [1 ]
Masse, Shirley [1 ]
Capai, Lisandru [1 ]
Fourie, Toscane [3 ]
Villarroel, Paola Mariela Saba [3 ]
Amroun, Abdennour [3 ]
Nurtop, Elif [3 ]
Vareille, Matthieu [1 ]
Blanchon, Thierry [2 ]
de Lamballerie, Xavier [3 ]
Charrel, Remi [3 ]
Falchi, Alessandra [1 ]
机构
[1] Univ Corse Pascal Paoli, Lab Virol, UR7310 Bioscope, F-20250 Corte, France
[2] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, IPLESP, F-75012 Paris, France
[3] Aix Marseille Univ, Unite Virus Emergents, IHU Mediterranee Infect, INSERM U1207,IRD 190, F-13005 Marseille, France
关键词
COVID-19; seroconversion; long-lasting immunity; antibodies; vaccination; INFECTION; COVID-19;
D O I
10.3390/ijerph192215257
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Uncertainties remain regarding the nature and durability of the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim: This study investigated immunoglobulin G response and neutralizing activity to evaluate the mean antibody concentrations and response duration induced by each vaccination regimen in a French adult population. Methods: A study including blood sampling and questionnaires was carried out from November 2020 to July 2021 with three separate follow-up phases. Spike proteins and neutralizing antibodies were quantified using ELISA and a virus-neutralization test. Results: Overall, 295 participants were included. Seroprevalences were 11.5% (n = 34), 10.5% (n = 31), and 68.1% (n = 201) in phases 1, 2, and 3, respectively. Importantly, 5.8% (n = 17) of participants lost their natural antibodies. Antibody response of participants with only a prior infection was 88.2 BAU/mL, significantly lower than those vaccinated, which was 1909.3 BAU/mL (p = 0.04). Moreover, the antibody response of vaccinated participants with a prior infection was higher (3593.8 BAU/mL) than those vaccinated without prior infection (3402.9 BAU/mL) (p = 0.78). Vaccinated participants with or without prior infection had a higher seroneutralization rate (91.0%) than those unvaccinated with prior infection (65.0%). Conclusion: These results demonstrated that single infection does not confer effective protection against SARS-CoV-2.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study
    Cordeiro Lima, Carlos Neandro
    Abreu, Isabella Nogueira
    Sacuena Rodrigues, Eliene Putira
    Freitas, Vanessa de Oliveira
    Sarmento Botelho, Bruno Jose
    Souza, Sandra Lima
    Cayres-Vallinoto, Izaura
    Guerreiro, Joao Farias
    Ishak, Ricardo
    Vallinoto, Antonio C. R.
    BMJ OPEN, 2022, 12 (02):
  • [22] Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece
    Dimopoulou, Dimitra
    Kyritsi, Maria
    Dadouli, Katerina
    Vergadi, Eleni
    Tsiligianni, Ekaterini
    Papadimitriou, Eleni
    Mavridi, Artemis
    Giannakopoulos, Spyridon
    Tsiourvopoulou, Georgia
    Palyvou, Maria
    Angeli, Evangelia
    Brikos, Nikitas
    Eleftheriou, Irini
    Spoulou, Vassiliki
    Michos, Athanasios
    Gkentzi, Despoina
    Siomou, Ekaterini
    Papaevangelou, Vassiliki
    Grivea, Ioanna
    Syrogiannopoulos, George
    Galanakis, Emmanouil
    Hadjichristodoulou, Christos
    Tsolia, Maria
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (01) : 439 - 449
  • [23] Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study
    Alcazar-Arroyo, Roberto
    Portoles, Jose
    Lopez-Sanchez, Paula
    Zalamea, Felipe
    Furaz, Karina
    Mendez, Angel
    Nieto, Luis
    Sanchez-Hernandez, Rosa
    Pizarro, Soledad
    Garcia, Alicia
    Pereira, Monica
    Gallego-Valcarcel, Eduardo
    Llopez-Carratala, Rosario
    Gadea-Girones, Ignacio
    Martin, Roberto
    Miranda, Blanca
    CLINICAL KIDNEY JOURNAL, 2021, 14 (07) : 1835 - 1844
  • [24] Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
    Adam, Mohamed Hussein
    Mohamoud, Jamal Hasan
    Mohamood, Abdiaziz S.
    Mohamed, Ahmed A.
    Garba, Bashiru
    Dirie, Najib Isse
    VACCINES, 2022, 10 (02)
  • [25] High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
    Naranbhai, Vivek
    Chang, Christina C.
    Beltran, Wilfredo F. Garcia
    Miller, Tyler E.
    Astudillo, Michael G.
    Villalba, Julian A.
    Yang, Diane
    Gelfand, Jeffrey
    Bernstein, Bradley E.
    Feldman, Jared
    Hauser, Blake M.
    Caradonna, Timothy M.
    Alter, Galit
    Murali, Mandakolathur R.
    Jasrasaria, Rashmi
    Quinlan, Joan
    Xerras, Dean C.
    Betancourt, Joseph R.
    Louis, David N.
    Schmidt, Aaron G.
    Lennerz, Jochen
    Poznansky, Mark C.
    Iafrate, A. John
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (12) : 1955 - 1959
  • [26] Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
    Mink, Sylvia
    Reimann, Patrick
    Fraunberger, Peter
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (06) : 1029 - 1043
  • [27] Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults
    Castro, Vitoria Tavares
    Chardin, Helene
    dos Santos, Juliana Amorim
    Barra, Gustavo Barcelos
    Castilho, Grazielle Rodrigues
    Souza, Paula Monteiro
    Magalhaes, Perola de Oliveira
    Acevedo, Ana Carolina
    Guerra, Eliete Neves Silva
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Vaccination time does not influence total anti-SARS-CoV-2 antibodies response
    Pighi, Laura
    De Nitto, Simone
    Salvagno, Gian Luca
    Lippi, Giuseppe
    CHRONOBIOLOGY INTERNATIONAL, 2024, 41 (02) : 309 - 310
  • [29] Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
    Lai, Chih-Cheng
    Wang, Jui-Hsiang
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 314 - 322
  • [30] Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
    Lippi, Giuseppe
    Henry, Brandon M.
    Pighi, Laura
    De Nitto, Simone
    Salvagno, Gian Luca
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (02): : 175 - 179